@beautyisfearless's perimenopause HRT claims, fact-checked
Quick answer
The creator underwent subcutaneous testosterone pellet implantation as part of perimenopause management, citing low libido as a primary symptom. Testosterone therapy for female sexual dysfunction has a recognized evidence base, but pellet delivery is specifically flagged in consensus guidelines for risk of supraphysiologic dosing and limited reversibility. Compounded bioidentical testosterone pellets are not FDA-approved, and their safety profile relative to conventional formulations has not been established in large controlled trials.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @beautyisfearless actually say?
She said she received "a bioidentical hormone of testosterone inserted straight into the booty" via a small subcutaneous pellet, described the procedure as a "small incision" with a "small rice-sized pelt," and framed this as part of her perimenopause management. She also implied low libido was a driving symptom. The video is less a medical claim and more a documentation of a real procedure she underwent. That context matters for evaluating it fairly.
What she did not claim: she did not promise specific outcomes, did not cite dosages, and did not tell viewers to skip other treatments. That restraint is worth acknowledging. What she did leave out is significant, though, and we will get into that.
Does the science back this up?
Testosterone therapy for women in perimenopause is legitimate medicine, but it is more complicated than this video suggests. The evidence base is real but narrow, and the delivery method she chose carries specific trade-offs that were not mentioned.
Testosterone pellet implants for women have been studied, and low-dose testosterone does have evidence supporting its use for hypoactive sexual desire disorder (HSDD) in postmenopausal women. Davis et al. (2019, The Lancet Diabetes and Endocrinology) conducted a systematic review of 36 randomized controlled trials and found testosterone improved sexual function in women, but noted the evidence for non-sexual outcomes like mood or energy was weak. The Global Consensus Position Statement on testosterone therapy for women, published the same year, endorsed testosterone for HSDD but specifically flagged pellets as a delivery method that can produce supraphysiologic levels, meaning levels higher than what a woman's body would naturally produce, which raises safety questions.
Perimenopause specifically, as opposed to postmenopause, is underrepresented in the existing trial data. Most studies recruited postmenopausal women. So the science supports the general concept, but the evidence for this exact scenario is thinner than a TikTok video implies.
What did they get wrong (or right)?
She got the basic procedure description right. Subcutaneous pellet insertion does involve a small incision, typically in the hip or gluteal area, and the pellet is roughly the size of a grain of rice. That matches standard clinical descriptions. Calling the hormone "bioidentical" is where things get murkier.
"Bioidentical" is a marketing term as much as a clinical one. Compounded bioidentical hormones are not FDA-approved, and the FDA has explicitly warned that claims about their safety or superiority over conventional hormone therapy are not supported by evidence. The North American Menopause Society has stated the same. She used the word without explaining what it means or does not mean, which is a real omission for 84,000 viewers.
The bigger issue is pellets specifically. Unlike gels or patches, pellets cannot be adjusted or removed once inserted. If a patient experiences side effects, including elevated testosterone, acne, hair loss, or mood changes, they have to wait weeks to months for the pellet to dissolve. Glaser and Dimitrakakis (2013, Maturitas) noted that pellet dosing is highly variable and difficult to standardize, raising legitimate clinical concerns about consistency.
What should you actually know?
Testosterone therapy for women with perimenopause symptoms is a real clinical option, and low libido is one of the symptoms with the strongest evidence base for testosterone intervention. None of that is snake oil. But the delivery method and the "bioidentical" framing deserve more scrutiny than this video gives them.
If you are considering this route, the questions worth asking your provider include: What is the target serum testosterone level, and how will it be monitored? What happens if levels come in too high? Why a pellet over a transdermal gel or cream, which are easier to dose-adjust? Is this provider operating under evidence-based protocols or selling a proprietary wellness package?
The Endocrine Society and NAMS both recommend against routine use of testosterone in women outside of specific indications, and neither organization currently endorses pellets as a preferred delivery method. That does not mean pellets are never appropriate, but it does mean the conversation with your doctor should be more involved than this video suggests.
- Monitor your testosterone levels before and after starting therapy.
- Ask about the reversibility of whatever delivery method you choose.
- "Bioidentical" does not automatically mean safer or more natural.
- Perimenopause-specific data on testosterone is limited compared to postmenopause data.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @beautyisfearless's perimenopause HRT claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@beautyisfearless's perimenopause HRT claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator underwent subcutaneous testosterone pellet implantation as part of perimenopause management, citing low libido as a primary symptom.
FormBlends verdict
The creator underwent subcutaneous testosterone pellet implantation as part of perimenopause management, citing low libido as a primary symptom. Testosterone therapy for female sexual dysfunction has a recognized evidence base, but pellet delivery is specifically flagged in consensus guidelines for risk of supraphysiologic dosing and limited reversibility. Compounded bioidentical testosterone pellets are not FDA-approved, and their safety profile relative to conventional formulations has not been established in large controlled trials.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator underwent subcutaneous testosterone pellet implantation as part of perimenopause management, citing low libido as a primary symptom. Testosterone therapy for female sexual dysfunction has a recognized evidence base, but pellet delivery is specifically flagged in consensus guidelines for risk of supraphysiologic dosing and limited reversibility. Compounded bioidentical testosterone pellets are not FDA-approved, and their safety profile relative to conventional formulations has not been established in large controlled trials.
- A 2019 systematic review of 36 RCTs (Davis et al., The Lancet Diabetes and Endocrinology) found testosterone improved sexual function in women, but evidence for mood, energy, or cognition benefits remains weak.
- The Global Consensus Position Statement on female testosterone therapy specifically flagged pellets as a delivery method that can produce supraphysiologic testosterone levels, which carries uncharacterized long-term risks.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- A 2019 systematic review of 36 RCTs (Davis et al., The Lancet Diabetes and Endocrinology) found testosterone improved sexual function in women, but evidence for mood, energy, or cognition benefits remains weak.
- The Global Consensus Position Statement on female testosterone therapy specifically flagged pellets as a delivery method that can produce supraphysiologic testosterone levels, which carries uncharacterized long-term risks.
- Pellets cannot be adjusted or removed after insertion. If side effects occur, including acne, hair thinning, or mood changes, the patient must wait weeks to months for natural dissolution.
- 'Bioidentical' is not an FDA-regulated term. Compounded bioidentical hormones lack the safety and efficacy data required of FDA-approved drugs, per a 2020 FDA advisory.
- Most clinical trial data on testosterone therapy in women was conducted in postmenopausal subjects, not perimenopausal ones, making direct evidence for this creator's situation thinner than the video implies.
- Transdermal testosterone (gels, creams) allows for dose adjustment and is more easily stopped than pellets, making it a preferred option in most evidence-based clinical guidelines.
- Low libido tied to perimenopause is a legitimate medical concern, not a wellness trend, but treatment decisions should involve testosterone level monitoring before and after initiation.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
the.kendraadams · TikTok creator
84.4K views on this video
Today I received my first Hormone Replacement Therapy (HRT) treatment!!! It's been a long time coming, and honestly, it's a relief to finally take this step. I've officially entered the peri-menopaus
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by the.kendraadams, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.